Biomea Fusion, Inc. (BMEA) Key Metrics
BMEA valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $63.0M
- Enterprise value
- $70.4M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 8.6 10-yr median 2.3
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- −0.30
BMEA key metrics, 2019–2025
Fiscal year ended December 31, 2025 · U.S. dollarsBMEA valuation Price multiples at each fiscal year-end price.
BMEA returns How much profit the business earns on the capital it uses.
BMEA per-share figures Results divided by the shares outstanding at year-end.
BMEA financial health Debt, liquidity and how easily interest is covered.
BMEA efficiency & capital use Working capital cycle and where the cash goes.
BMEA valuation history
BMEA returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BMEA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BMEA price vs earnings per share
BMEA key metrics
2019–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Valuation | |||||||
| Market capitalization | $64.8M | $140.1M | $495.2M | $246.8M | $177.7M | — | — |
| Enterprise value | $10.5M | $90.6M | $328.7M | $136.0M | $7.1M | — | — |
| Price / book | 2.2 | 2.7 | 2.9 | 2.3 | 1.0 | — | — |
| Earnings yield | −95.4% | −98.8% | −23.7% | −32.4% | −23.2% | — | — |
| Free cash flow yield | −108.7% | −85.8% | −20.2% | −25.7% | −21.7% | — | — |
| Shareholder yield (dividends + buybacks) | — | — | — | 0.0% | 0.0% | — | — |
| Share price at fiscal year-end | $1.24 | $3.88 | $14.52 | $8.43 | $7.45 | — | — |
| Per share | |||||||
| Revenue per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Earnings per share | −$1.18 | −$3.83 | −$3.44 | −$2.73 | −$1.73 | — | — |
| Operating cash flow per share | −$1.35 | −$3.32 | −$2.83 | −$2.13 | −$1.49 | — | — |
| Free cash flow per share | −$1.35 | −$3.33 | −$2.93 | −$2.17 | −$1.62 | — | — |
| Cash per share | $1.07 | $1.61 | $5.19 | $3.86 | $7.27 | — | — |
| Book value per share | $0.57 | $1.43 | $4.96 | $3.71 | $7.49 | — | — |
| Tangible book value per share | $0.57 | $1.43 | $4.96 | $3.71 | $7.49 | — | — |
| Capex per share | $0.00 | $0.01 | $0.10 | $0.04 | $0.13 | — | — |
| Debt per share | $0.03 | $0.24 | $0.30 | $0.08 | $0.12 | — | — |
| Shares outstanding | 52.2M | 36.1M | 34.1M | 29.3M | 23.9M | — | — |
| Change in shares outstanding | +44.7% | +5.9% | +16.5% | +22.7% | — | — | — |
| Returns & profitability | |||||||
| Return on equity (ROE) | −152.4% | −125.4% | −84.4% | −55.7% | −44.8% | −206.8% | — |
| Return on assets (ROA) | −89.2% | −98.9% | −71.2% | −50.8% | −33.2% | −17.0% | −452.1% |
| Return on tangible assets | −105.5% | −173.2% | −58.6% | −61.9% | −22.2% | −8.5% | −452.1% |
| Financial health | |||||||
| Total debt | $1.6M | $8.8M | $10.3M | $2.3M | $2.9M | $259,000 | — |
| Cash & short-term investments | $55.8M | $58.3M | $176.9M | $113.0M | $173.5M | $61.7M | $239,000 |
| Net debt | −$54.2M | −$49.5M | −$166.6M | −$110.8M | −$170.7M | −$61.4M | −$239,000 |
| Debt / equity | 0.05 | 0.17 | 0.06 | 0.02 | 0.02 | 0.05 | — |
| Debt / assets | 0.03 | 0.11 | 0.05 | 0.02 | 0.02 | 0.00 | — |
| Current ratio | 5.23 | 3.15 | 7.84 | 6.17 | 38.08 | 38.43 | 0.93 |
| Quick ratio | 5.23 | 3.15 | 7.84 | 6.17 | 38.08 | 38.43 | 0.93 |
| Interest coverage | — | — | — | -46.3 | -416.7 | — | — |
| Working capital | $46.9M | $46.7M | $156.3M | $98.7M | $171.9M | $60.6M | −$21,000 |
| Invested capital | −$24.7M | $2.1M | $2.7M | −$2.2M | $8.1M | −$56.3M | −$260,000 |
| Tangible asset value | $29.6M | $51.6M | $169.2M | $108.5M | $178.8M | $5.2M | −$21,000 |
| Net current asset value | $29.0M | $40.0M | $148.5M | $97.1M | $169.6M | $4.9M | −$21,000 |
| Graham net-net per share | $0.51 | $0.83 | $4.29 | $3.15 | $6.98 | — | — |
| Capital allocation | |||||||
| Share buybacks (net) | — | — | — | $0 | $0 | — | — |
| Capex / depreciation | 0.00 | 0.21 | 2.22 | 1.49 | 12.73 | 0.39 | 6.38 |
| Efficiency | |||||||
| Days payables outstanding | 2,093.8 | 2,065.4 | 594.2 | 1,179.3 | 393.7 | 1,379.8 | — |
| Payables turnover | 0.17 | 0.18 | 0.61 | 0.31 | 0.93 | 0.26 | — |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average payables | $8.1M | $9.9M | $6.8M | $4.1M | $1.0M | $499,000 | $271,000 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from BMEA's annual financial statements (latest annual report filed March 24, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
BMEA valuation and financial ratios
Biomea Fusion earned a return on equity of −152.4% in fiscal 2025. It ended the year with $1.6 million of debt and $55.8 million in cash and short-term investments, a net cash position of $54.2 million.
See the BMEA income statement, the BMEA chart for price history, or the BMEA stock overview for the latest quote and news.
BMEA key metrics FAQ
What is Biomea Fusion's return on equity?
Biomea Fusion's return on equity (ROE) was −152.4% in fiscal 2025: net income of -$61.8 million on average shareholders' equity of $40.6 million.
How much debt does Biomea Fusion have?
Biomea Fusion had total debt of $1.6 million at the end of fiscal 2025, a debt-to-equity ratio of 0.05 and more cash than debt.
What is Biomea Fusion's free cash flow yield?
Biomea Fusion generated -$70.4 million of free cash flow in fiscal 2025, a free cash flow yield of −108.7% on its market value at year-end ($64.8 million).
What is Biomea Fusion's current ratio?
Biomea Fusion's current ratio was 5.23 at the end of fiscal 2025: current assets were 5.23 times current liabilities.